
Enzamide 40 mg contains enzalutamide, a nonsteroidal androgen receptor inhibitor prescribed primarily for castration-resistant prostate cancer (CRPC)—both metastatic (spread beyond the prostate) and non-metastatic forms.
| Generic Name | Enzalutamide |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 56 Capsules |
| Prescribed For | Prostate Cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.